Regeneron Pharmaceuticals, Inc. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:07 pm Purchase | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | REGENERON PHARMACEUTICALS INC. REGN | 180,910 1.840% | 180,910 (New Position) | Filing |